Association of Low‐Density Lipoprotein Cholesterol Levels During Statin Treatment With Cardiovascular and Renal Outcomes in Patients With Moderate Chronic Kidney Disease

Association of Low‐Density Lipoprotein Cholesterol Levels During Statin Treatment With Cardiovascular and Renal Outcomes in Patients With Moderate Chronic Kidney Disease

Background The benefit of low‐density lipoprotein cholesterol (LDL‐C) levels in chronic kidney disease populations remains unclear. This study evaluated the cardiovascular and renal outcomes in patients with stage 3 chronic kidney disease with different LDL‐C levels during statin treatment. Methods...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Chieh‐Li Yen, Pei‐Chun Fan, Cheng‐Chia Lee, Jia‐Jin Chen, George Kuo, Yi‐Ran Tu, Pao‐Hsien Chu, Hsiang‐Hao Hsu, Ya‐Chung Tian, Chih‐Hsiang Chang
Formáid: Alt
Teanga:English
Foilsithe / Cruthaithe: Wiley 2022-10-01
Sraith:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Ábhair:
cardiovascular disease
chronic kidney disease
low‐density lipoprotein cholesterol
statin
stroke
Rochtain ar líne:https://www.ahajournals.org/doi/10.1161/JAHA.122.027516

Ar líne

https://www.ahajournals.org/doi/10.1161/JAHA.122.027516

Míreanna comhchosúla